Article Versions Notes

Romano A, Friuli M, Del Coco L, Longo S, Vergara D, Del Boccio P, Valentinuzzi S, Cicalini I, Fanizzi FP, Gaetani S, et al. Chronic Oleoylethanolamide Treatment Decreases Hepatic Triacylglycerol Level in Rat Liver by a PPARγ/SREBP-Mediated Suppression of Fatty Acid and Triacylglycerol Synthesis. Nutrients. 2021; 13(2):394. https://doi.org/10.3390/nu13020394

Romano, Adele, Marzia Friuli, Laura Del Coco, Serena Longo, Daniele Vergara, Piero Del Boccio, Silvia Valentinuzzi, Ilaria Cicalini, Francesco P. Fanizzi, Silvana Gaetani, and et al. 2021. "Chronic Oleoylethanolamide Treatment Decreases Hepatic Triacylglycerol Level in Rat Liver by a PPARγ/SREBP-Mediated Suppression of Fatty Acid and Triacylglycerol Synthesis" Nutrients 13, no. 2: 394. https://doi.org/10.3390/nu13020394

Romano, A., Friuli, M., Del Coco, L., Longo, S., Vergara, D., Del Boccio, P., Valentinuzzi, S., Cicalini, I., Fanizzi, F. P., Gaetani, S., & Giudetti, A. M. (2021). Chronic Oleoylethanolamide Treatment Decreases Hepatic Triacylglycerol Level in Rat Liver by a PPARγ/SREBP-Mediated Suppression of Fatty Acid and Triacylglycerol Synthesis. Nutrients, 13(2), 394. https://doi.org/10.3390/nu13020394